willdate

115 POSTS 0 COMMENTS

Review looks at TAVI device selection and concludes head-to-head studies needed

Transcatheter aortic valve implantation (TAVI) device selection should be guided by patient, anatomic, and device-specific factors, a review of the considerations for optimal device...

The challenges of the modern cath lab

Over the last decade, the cath lab has transformed. Interventional cardiologists are now not only treating increasingly complex lesions, such as chronic total occlusions,...

V-Wave closes US$98 million financing round

V-Wave has closed a Series C financing extension of up to US$98 million, assuring capital to complete clinical trials for the Ventura interatrial shunt...

Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices

Medtronic has received Breakthrough Device Designation status from the US Food and Drug Administration (FDA) for the Tyrx absorbable antibacterial driveline wrap, which is...

Recurrent heart attacks declining, but overall rate remains high

After surviving a heart attack, the proportion of patients who experience a repeat attack within a year fell between 2008 and 2017, with a...

Abbott receives CE mark for the next-generation Mitraclip

Abbott has today announced it has received CE mark approval for its fourth-generation MitraClip transcatheter mitral valve repair system. Known as MitraClip G4, the...

IVUS linked to favourable PCI outcomes, but uptake is low

A study of US Medicare patients undergoing percutaneous coronary intervention (PCI) has found that the use of intravascular ultrasound (IVUS) resulted in a lower...

TCT Connect 2020 to feature late-breaking interventional cardiology studies

The Cardiovascular Research Foundation (CRF) has announced that over 30 late-breaking trial and science presentations that will be reported at TCT Connect (14–18 October,...

J Dawn Abbott

J Dawn Abbott is the director of interventional cardiology and an associate professor of medicine in the department of medicine at the Warren Alpert...

Aspirin-free monotherapy after coronary artery stenting is feasible and safe

Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent implantation demonstrated feasibility and safety without any stent thrombosis in selected low-risk patients with stable coronary artery...

VitalConnect begins TELESTAR-TAVR remote monitoring study

VitalConnect has announced the commencement of the TELESTAR-TAVR clinical study—Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients)—monitoring patients undergoing...

AHA calls for awareness of medication-induced arrhythmias

Healthcare professionals should become more familiar with medications that cause arrhythmias, according to a new scientific statement from the American Heart Association (AHA), published...

Cardiac MRI effective at identifying myocarditis in athletes

Cardiac magnetic resonance imaging (MRI) is effective in identifying inflammation of the heart muscle in athletes and can help determine when those who have...

Older patients “unaware” of heart valve disease risks

Survey results published to mark Heart Valve Disease Awareness Week show that older Europeans are unaware of the risks of common, serious, but treatable...

A variety of tools are now available for physiological assessment

Multiple studies have shown that fractional flow reserve (FFR) is a valuable modality for assessing the functional significance of coronary lesions. However, it does...

TIDES-ACS confirms performance of Hexacath’s titanium-nitride-oxide coated stent

Results of the TIDES-ACS randomised controlled trial, confirming the superior safety and sustained non-inferior efficacy of the Bio-Active Stent technology (Hexacath) at 18 months...

Medtronic begins early feasibility study of the Intrepid transcatheter valve system

Medtronic has announced  US Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid transcatheter tricuspid valve replacement (TTVR)...

Patient-specific, 3D printed aortic valve model used in preparation for TAVR...

Researchers from the University of Minnesota, with support from Medtronic, have developed a process for multi-material 3D printing of models of the heart’s aortic...

Cardiac Dimensions receives Australian regulatory approval for its Carillon mitral contour...

Cardiac Dimensions has announced that Australia’s Therapeutic Goods Administration (TGA) has approved its Carillon mitral contour system, a right heart transcatheter mitral valve repair...

Fujifilm Sonosite receives FDA clearance for COVID-19 use of its cardiac...

Fujifilm Sonosite has received 510(k) clearance from the US Food & Drug Administration (FDA) for the company's point-of-care ultrasound portfolio to support healthcare providers...

Japan and the USA see an increase in PCI procedures

Japan and the USA have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs...

First patient enrolled in TRANSFORM-1 study of MagicTouch DCB

Concept Medical has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch...

CryoLife acquires Ascyrus Medical

CryoLife has announced the acquisition of Ascyrus Medical, developer of the Ascyrus Medical Dissection Stent (AMDS), an aortic arch remodelling device used for the...

ACC announces revised dates for ACC.21

The American College of Cardiology (ACC) has announced that its 70th Annual Scientific Session, ACC.21 taking place in Atlanta, USA, will be held across...

BioVentrix resumes ALIVE trial after COVID-19 pause

BioVentrix has announced the resumption of cases in the pivotal ALIVE Trial studying Less Invasive Ventricular Enhancement, or LIVE Therapy, using the Revivent TC...

ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk...

An invasive approach involving either percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) may be beneficial in high risk stable ischaemic heart...

ESC 2020 Congress: No discernible effect on saphenous vein graft patency...

According to findings of the POPular CABG trial, the addition of ticagrelor to aspirin after coronary artery bypass graft (CABG) surgery did not reduce...

Philips launches latest version of its Azurion imaging platform

Royal Philips has announced the next-generation of its Azurion image-guided therapy platform, designed to improve the quality and efficiency of interventional procedures. The Azurion...

Miracor secures financing to support PiCSO clinical study

Miracor Medical has announced the closing of a €24 million series-E round of financing. The round was led by a new corporate strategic investor...

ESC 2020 Congress: AF associated with long-term mortality in primary PCI...

Atrial fibrillation (AF) is associated with long-term mortality in patients undergoing primary percutaneous coronary intervention (PCI), irrespective of left ventricular (LV) function, a study...

ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy

The POPular TAVI trial has challenged current recommendations on antiplatelet treatment after transcatheter aortic valve implantation (TAVI) in patients not taking oral anticoagulation. Findings...

ESC Congress 2020: Mavacamten improves heart function in HCM patients

Mavacamten (MyoKardia) improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM), according to results of the EXPLORER-HCM trial presented in a...

ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling

Transcatheter mitral valve replacement (TMVR) with the Tendyne device (Abbott) results in favourable left-sided chamber remodelling in the majority of patients one month after...

ESC Congress 2020: Society publishes new guidelines on congenital heart disease,...

The European Society of Cardiology (ESC) has issued new guidelines, published online today in the European Heart Journal and on the ESC website, for...

ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients...

Empagliflozin reduces the risk of cardiovascular death or hospitalisation for heart failure in patients with heart failure and a reduced ejection fraction (HFrEF), according...

FDA approves revised labelling for Medtronic’s Evolut valve

Medtronic has announced that the US Food and Drug Administration (FDA) has approved revised commercial labelling for the Evolut transcatheter aortic valve replacement (TAVR)...

Cardiovascular News 58 – August 2020

Meta analysis puts spotlight on optimal DAPT duration Cardiologists warn of long-term impact of COVID-19 News from 2020 PCR e-Course In profile: J...

Cardiovascular News 58 – August 2020: US Edition

Meta analysis puts spotlight on optimal DAPT duration Cardiologists warn of long-term impact of COVID-19 News from 2020 PCR e-Course In profile: J...

Make confident diagnostic decisions on coronary artery diseases – fast

In this educational supplement, sponsored by Siemens Healthineers, Cardiovascular News explores how advanced imaging systems are being used in modern cath labs. Stephan Achenbach...

Philips expands cardiovascular ultrasound portfolio with Affiniti CVx

Philips announced today the latest addition to its portfolio of dedicated cardiovascular ultrasound solutions—Affiniti CVx. The system aims to support cardiology departments in delivering...

AHA issues guidance on stroke prevention in heart surgery patients

Guidelines for reducing the risk of stroke in patients undergoing heart surgery have been detailed in an American Heart Association (AHA) scientific statement, “Considerations...

Heart Rhythm Society publishes Cardiovascular Digital Health Journal

The Heart Rhythm Society has announced the publication of the inaugural issue of the Cardiovascular Digital Health Journal. The new journal focuses on the...

Chinese study suggests STEMI patients had increased mortality risk during COVID-19...

The risk of in-hospital death and in-hospital heart failure increased for ST-elevation myocardial infarction (STEMI) patients in China during the early stages of the...

Heart teams and interventional cardiologists often differ over recommendations for multivessel...

A study comparing recommendations from a heart team versus those of an interventional cardiologist for the treatment of patients with multivessel coronary artery disease...

Women “underrepresented” in heart failure studies

  Representation of women leading heart failure research remains limited, according to a study published in Circulation: Heart Failure, which may create a barrier to...

Transcatheter tricuspid valve replacement “low risk” for complications

Transcatheter tricuspid valve replacement in the setting of trans-tricuspid pacemaker leads without extraction or re-replacement can be performed safely with a low risk of...

Philips introduces Omniwire for coronary artery procedures

Royal Philips has announced the introduction of OmniWire, a solid core pressure wire for coronary artery interventional procedures. With a solid core construction, physicians...

ESC 2020 Congress: Digital platform takes congress to a wider audience

Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking place from 29 August–1 September, the event’s scientific chair Marco Roffi (University Hospitals...

Cardiovascular risk factors linked to COVID-19 complications and death

COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardiovascular complications while hospitalised, and more likely to die from COVID-19...

10-year data on VIVO ISAR drug-eluting stent published in JACC

Translumina has announced the publication of 10-year follow-up data on its dual-drug polymer-free drug-eluting stent (DES), VIVO ISAR, in the Journal of the American...

Digital learning is becoming a part of the “new normal”

With whole sections of society migrating online during the COVID-19 pandemic, e-learning has risen to the fore in medical education. Thomas Binder, founder and...

Stress may have clinical implications for heart failure patients

Mental stress and anger may have clinical implications for patients with heart failure according to a study published in the Journal of Cardiac Failure. In...

Biosensors announces enrolment of first patient in REFORM pivotal trial

Biosensors announced today the enrolment of the first patient in REFORM—a prospective, randomised, non-inferiority trial to determine the safety and efficacy of the Biolimus...

Survey reveals patient attitudes to heart valve procedures

A US survey released by patient advocacy group Heart-Valve-Surgery.com, with support by Medtronic, has found that nearly half (49%) of heart valve patients say...

InnovHeart secures US$24 million finance package

InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease—has announced the closing of a US$23.8 million round...

JAHA retracts paper calling for end to cardiology diversity programmes

The Journal of the American Heart Association (JAHA) has retracted a paper published in March 2020, which drew criticism due to its conclusions about race and the role of affirmative action within...

FORWARD PRO study of Evolut Pro valve meets safety and efficacy...

Thirty-day clinical outcomes from the FORWARD PRO international study of the Evolut Pro (Medtronic) self-expanding transcatheter aortic valve, published in EuroIntervention, have confirmed the...

CardioMech secures financing for mitral valve repair study

CardioMech, developer of a transfemoral, transseptally delivered mitral valve repair technology, announced today it has closed on its Series A financing led by a...

Meta-analysis advocates “personalised approach” to DAPT duration after PCI

A meta-analysis of 24 randomised controlled trials assessing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stents shows a net clinical...

Eko and AstraZeneca announce digital cardiovascular health partnership

Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart...

FDA issues EUA for left-sided Impella to provide left ventricular unloading

The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for left-sided Impella heart pumps to provide left ventricular unloading...

Tailoring therapy and maximising TAVI programme efficiency

In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores the use of transcatheter aortic valve implantation (TAVI), including latest developments in techniques...

Using remote learning to improve high-risk PCI outcomes

As interventional cardiology continues to grow with higher risk patients and more complex coronary, writes Rajan Patel (Ochsner Clinic Foundation, Jefferson, USA), the need...

Frankfurt study finds high rate of cardiac complications in recovered COVID-19...

A German study of recently-recovered COVID-19 patients examined using magnetic resonance imaging (MRI) revealed cardiac involvement in 78% of patients, and ongoing myocardial inflammation...

Japanese study finds high survival rates with use of Impella heart...

A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump has found that the use of Impella is associated with...

Low one-year rate of mortality found in mitral valve-in-valve replacement using...

One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (Edwards Lifesciences) transcatheter heart valve have been published in JAMA: Cardiology, reporting low all-cause...

Keystone Heart announces first case using TriGUARD 3 CEP device

Keystone Heart has announced completion of the first worldwide commercial case using the TriGUARD 3 cerebral embolic protection (CEP) device. Pieter Stella, assistant professor,...

NSAIDs increase bleeding risk after myocardial infarction, Korean study finds

Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart attack patients significantly increased the risk for cardiovascular and bleeding events post-heart attack in...

American College of Cardiology to launch JACC: Asia

The American College of Cardiology (ACC) is expanding its JACC family of peer-reviewed journals to include JACC: Asia, which will publish original manuscripts focused...

Abiomed gains approval for data streaming from the Impella console

The US Food and Drug Administration (FDA) has approved one-way digital data streaming during patient support from Abiomed’s Automated Impella Controller (AIC), the external...

TAVI or surgical valve replacement “similarly effective” in men and women

Aortic valve replacement, using either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) approaches appear to be similarly effective for males...

Caption Health gains FDA approval for updates to its cardiac AI...

Caption Health, a developer of medical artificial intelligence (AI) technology, has received US Food and Drug Administration (FDA) 510(k) clearance for an updated version...

Mavacamten granted Breakthrough Therapy Designation

MyoKardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to mavacamten, a novel, oral, allosteric modulator of...

Funding secured to further study of AI systems for cardiovascular health

Digital health and artificial intelligence (AI) company Eko has been awarded a US$2.7 million Small Business Innovation Research (SBIR) grant by the National Institutes...

Genetic testing could aid decision-making in cardiovascular healthcare

Genetic testing and counselling for inherited cardiovascular diseases may help patients and their families make informed decisions about managing their heart health, according to...

Race and gender bias may impact the timing of treatment for...

Findings of a US investigation of clinician race and gender bias in decision-making around heart failure therapies suggests that African American women may be...

Inspiron sirolimus eluting stent receives CE mark approval

Scitech has announced that the Inspiron coronary sirolimus eluting stent has received CE mark approval. The device is a third generation drug eluting stent...

Next-generation Watchman LAAC device gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman FLX left atrial appendage closure (LAAC) device. The device is...

LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

LifeSignals Group has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the LifeSignals ECG Remote Monitoring Patch platform. The...

LivaNova launches Perceval Plus sutureless heart valve in Europe

LivaNova has announced that the advanced Perceval Plus sutureless surgical aortic heart valve is now available for commercial release in Europe, having successfully completed...

Women taking beta blockers for hypertension may have higher risk of...

Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a nearly 5% higher risk for heart failure than men...

Fall in hospitalisations for acute coronary syndrome seen during COVID-19

A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with a fall in the number of acute coronary syndrome hospitalisations during the...

FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit

Edwards Lifesciences has announced approval from the US Food and Drug Administration (FDA) for the KONECT RESILIA aortic valved conduit (AVC), a ready-to-implant solution...

AHA Scientific Sessions 2020 to be held virtually

The American Heart Association (AHA) has announced that its 2020 Scientific Sessions will be presented as a 100% virtual experience in light of the...

Half of COVID-19 patients receiving echocardiograms show heart abnormalities

Around half of COVID-19 patients who received an echocardiogram in-hospital showed abnormalities in heart function, according to a prospective international survey funded by the...

FDA grants Breakthrough Device Designation for Doraya temporary catheter

Revamp Medical has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Doraya device, a temporary intravenous...

ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR...

ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rapid Exchange FFR MicroCatheter, the second-generation microcatheter for use with its...

Venus Medtech and Pi-Cardia to bring Leaflex catheter to Chinese market

Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex technology to China. Pi-Cardia's Leaflex catheter performs mechanical scoring of valve calcification, restoring leaflets' mobility...

Carag Bioresorbable Septal Occluder approved for US IDE trial

US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been granted for the Carag Bioresorbable Septal Occluder (CBSO). The CE-marked CBSO is...

PCR e-Course 2020: Roll-in trial finds high device success rate for...

Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high implant success rate and a low procedural complication rate in...

PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs...

Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, major bleeding and all-cause mortality, in atrial fibrillation (AF) patients with a high...

Smartphone app uses can identify lung congestion in heart failure patients

Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing early intervention before their condition deteriorates, a study presented...

Philips gains FDA clearance for the use of its ultrasound portfolio...

Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a wide range of...

FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

The US Food and Drug Administration (FDA) has expedited clearance of an update to software from Caption Health, a medical artificial intelligence (AI) company,...

Boston Scientific announces positive PINNACLE FLX study results

Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left...

LifeSignals receives CE mark for the ECG Remote Monitoring Patch

LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a disposable wireless remote monitoring system, intended for use by healthcare...

iRhythm offers home enrolment of Zio monitoring devices

iRhythm Technologies has announced a virtual platform to support patients and clinicians in the wake of COVID-19 by offering home enrolment for the company’s...

US heart societies express concern over using hydroxychloroquine and azithromycin for...

Presidents of leading cardiac organisations, including the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS), have...

Webinar: Cardiovascular specialists detail COVID-19 strategies

Cardiovascular specialists from across the globe shared current knowledge and key experience of managing COVID-19 patients as part of a webinar organised by the...

AHA issues oxygenation and ventilation guidance for healthcare providers

The American Heart Association (AHA), in conjunction with the American Association for Respiratory Care (AARC) and American Society of Anesthesiologists (ASA) is offering guidance...

Athena Poppas begins ACC presidency

Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC). Her term officially began at the close of the...

Cardiologists share COVID-19 insights

Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, in a series of videos produced by the European Society of...

Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...

Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study

Onyx One Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolute Onyx drug-eluting stent (DES) in high bleeding risk (HBR)...

Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis...

Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low risk of death or disabling stroke at 30 days in...

AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...

Append Medical share clinical proof-of-concept results for internal sealing of LAA

Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and...

VitalConnect adds arrhythmia detection to its remote monitoring software

VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, VitalConnect now offers physicians the ability to...

AI-guided cardiac imaging system given FDA authorisation

The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acquisition of cardiac ultrasound, or echocardiography, images. The...

First patient enrolled in PREDICT-LAA clinical trial

FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The trial is led by Righshospitalet (Copenhagen, Denmark) and aims...

ACC makes senior staff appointments

The American College of Cardiology (ACC) has announced several promotions and structural changes within its senior staff. The College said that the staff changes...

FDA grants Breakthrough designation for ECG-based algorithm

The US Food and Drug Administration has granted Breakthrough Device designation to the digital health and artificial intelligence (AI) company Eko for an echocardiogram...

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

The results of the safety profile and efficacy of Lixiana study
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...

AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary...

Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor System at the 2019 American Heart Association (AHA) Scientific Sessions (16–18 November,...

Left atrial appendage closure associated with a decreased stroke risk in...

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...